Burkitt's lymphoma: Historical background and recent insights into classification and pathogenesis

Annals of Otology, Rhinology and Laryngology

Volumn 109, Issue 7, 2000, Pages 693-702

  Carbone, Antonino ^a   Rinaldo, Alessandra ^b   Canzonieri, Vincenzo ^a   Gaidano, Gianluca ^c   Gloghini, Annunziata ^a   Ferlito, Alfio ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CLINICAL FEATURE; DISEASE CLASSIFICATION; EPSTEIN BARR VIRUS; GENETIC ANALYSIS; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; ONCOGENE C MYC; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0342646993     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940010900716     Document Type: Article

References (88)

1. Wright DH. What is Burkitt's lymphoma? [Editorial]. J Pathol 1997;182:125-7.
2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
3. Davies JNP, Elmes S, Hutt MSR. Mtimavalye LAR, Owor R, Lorna S. Cancer in African community, 1897-1956. An analysis of the records of Mengo Hospital. Kampala, Uganda. Part I. Br Med J 1964;1:259-64.
4. Edington GM. Malignant disease in the Gold Coast. Br J Cancer 1956;10:41-54.
5. Thijs A. Considerations sur le tumeurs malignes des indigenes du Congo belge et du Ruanda-Urundi. A propos de 2,536 cas. Ann Soc Belg Med Trop 1957;37:483-514.
6. De Smet MP. Observations cliniques de tumeurs malignes des tissus reticuloendotheliaux et des tissus hemolymphopoietiques au Congo. Ann Soc Belg Med Trop 1956;36:53-70.
7. Burkitt D. Sarcoma involving jaws in African children. Br J Surg 1958;46:218-25.
8. O'Conor GT, Davies JNP. Malignant tumors in African children. J Pediatr 1960;56:526-35.
9. O'Conor GT, Rappaport H, Smith EB. Childhood lymphoma resembling Burkitt's lymphoma in the United States. Cancer 1965;18:411-7.
10. Dorfman RF. Childhood lymphosarcoma in St Louis, Missouri, clinically and histologically resembling Burkitt's lymphoma. Cancer 1965;18:418-30.
11. Wright DH. Burkitt's tumour in England. A comparison with childhood lymphosarcoma. Int J Cancer 1966,1:503-4.
12. Vecchione A, Landi E. Su un caso di linfosarcoma a localizzazione ovarica. Quad Clin Ostet Ginecol 1966;21:799-810.
13. Cossman J, Berard CW. Histopathology of childhood non-Hodgkin's lymphomas. In: Graham-Pole J, ed. Non-Hodgkin's lymphomas in children. New York, NY: Masson, 1980;13-36.
14. Berard CW, O'Conor GT, Thomas LB, Torloni H. Histopathological definition of Burkitt's tumor. Bull World Health Organ 1969;40:601-7.
15. Doll DC, List AF. Burkitt's lymphoma in a homosexual [Letter]. Lancet 1982;1:1026-7.
16. Ziegler JL, Drew WL, Miner RC, et al. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet 1982;2:631-3.
17. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565-70.
18. Lowenthal DA, Straus DJ, Campbell SW, Gold JWM, Clarkson BD, Koziner B. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988;61:2325-37.
19. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988;108: 744-53.
20. Raphael M, Gentilhomme O, Tulliez M, Byron P-A. Diebold J, The French Study Group of Pathology for Human Immunodeficiency Virus - Associated Tumors. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991;115:15-20.
21. Carbone A, Tirelli U, Vaccher E, et al. A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy. Cancer 1991;68:842-52.
22. Rappaport H. Tumors of the hematopoietic system. In: Atlas of tumor pathology. Section 3. Fascicle 8. Washington, DC: Armed Forces Institute of Pathology, 1966:97-161.
23. Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 1974;34:1488-503.
24. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982;49: 2112-35.
25. Hui PK, Feller AC, Lennert K. High-grade non-Hodgkin's lymphoma of B-cell type. I. Histopathology. Histopathology 1988;12:127-43.
26. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1988;1:292-3.
27. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink H-K. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 1999;111 (suppl 1):S8-S12.
28. Cossman J. Diffuse, aggressive non-Hodgkin's lymphomas. In: Jaffe ES, ed. Major problems in pathology: surgical pathology of the lymph nodes and related organs. Vol 16. Philadelphia, Pa: Saunders, 1985:203-17.
29. Grogan TM, Warnke RA, Kaplan HS. A comparative study of Burkitt's and non-Burkitt's "undifferentiated" malignant lymphoma. Immunologic, cytochemical, ultrastructural, cytologic, histopathologic, clinical and cell culture features. Cancer 1982;49:1817-28.
30. Payne CM, Grogan TM, Cromey DW, Bjore CG Jr, Kerrigan DP. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas. Lab Invest 1987;57:200-18.
31. Pavlova Z, Parker JW, Taylor CR, Levine AM, Feinstein DI, Lukes RJ. Small noncleaved follicular center cell lymphoma: Burkitt's and non-Burkitt's variants in the US. II. Pathologic and immunologic features. Cancer 1987;59:1892-902.
32. Mann RB, Jaffe ES, Braylan RC, et al. Non-endemic Burkitt's lymphoma. A B-cell tumor related to germinal centers. N Engl J Med 1976;295:685-91.
33. Carbone A, Gaidano G, Gloghini A, et al. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus - encoded latent membrane protein - 1 expression. Am J Pathol 1997;150:155-65.
34. Carbone A, Gaidano G, Gloghini A, et al. Differential expression of BCL-6, CD138/syndecan-1 and EBV-encoded latent membrane protein - 1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome - related non-Hodgkin's lymphomas. Blood 1998;91:747-55.
35. Garcia CF, Weiss LM, Warnke RA. Small noncleaved cell lymphoma. An immunophenotypic study of 18 cases and comparison with large cell lymphoma. Hum Pathol 1986;17: 454-61.
36. Brownell MD, Sheibani K, Battifora H, Winberg CD, Rappaport H. Distinction between undifferentiated (small non-cleaved) and lymphoblastic lymphoma. An immunohistologic study on paraffin-embedded, fixed tissue sections. Am J Surg Pathol 1987;11:779-87.
37. Billaud M, Rousset F, Calender A, et al. Low expression of lymphocyte function - associated antigen (LFA) - 1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. Blood 1990;75:1827-33.
38. Raphael MM, Audouin J, Lamine M, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome - related non-Hodgkin's lymphomas: correlation with histologic features in 36 cases. Am J Clin Pathol 1994;101:773-82.
39. Carbone A, Gloghini A, Gaidano G, et al. AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 1995;103:561-7.
40. Gloghini A, De Paoli P, Gaidano G, Franceschi S, Carbone A. High frequency of CD45RO expression in AIDS-related B-cell non-Hodgkin's lymphomas. Am J Clin Pathol 1995; 104:680-8.
41. Dalla-Favera R. Chromosomal translocations involving the c-myc oncogene in lymphoid neoplasia. In: Kirsch IR, ed. The causes and consequences of chromosomal aberrations. Boca Raton, Fla: CRC Press, 1993:312.
42. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 1982;79:7824-7.
43. Dalla-Favera R, Martinotti S, Gallo RC, Erikson J, Croce CM. Translocation and rearrangements of the c-myc oncogene in human undifferentiated B-cell lymphomas. Science 1983;219: 963-7.
44. Davis M, Malcolm S, Rabbits TH. Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells. Nature 1984;308:286-8.
45. Hollis GF, Mitchell KF, Battey J, et al. A variant translocalion places the lambda immunoglobulin genes 3′ to the c-myc oncogene in Burkitt's lymphoma. Nature 1984;307:752-5.
46. Taub R, Kirsch I, Morton C, et al. Translocation of c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A 1982;79:7837-41.
47. ar-Rushdi A, Nishikura K, Erikson J, Watt R, Rovera G, Croce CM. Differential expression of the translocated and untranslocaled c-myc oncogene in Burkitt's lymphoma. Science 1983;222:390-3.
48. Hayday AC, Gillies SD, Saito H, et al. Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy chain locus. Nature 1984;307:334-40.
49. Rabbits TH, Forster A, Baer R, Hamlyn PH. Transcriptional enhancer identified where the human C immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt's lymphoma. Nature 1983;306:806-9.
50. Lombardi L, Newcomb EW, Dalla-Favera R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 1987;49:161-70.
51. Magrath IT. Prospects for the therapeutic use of antisense oligonucleotides in malignant lymphomas. Ann Oncol 1994;5 (suppl 1):S67-S70.
52. McManaway ME, Neckers LM, Loke SL, et al. Tumor-specific inhibition of lymphoma growth by an antisense oligodeoxy-nucleotide. Lancet 1990;335:808-11.
53. Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985;318:533-8.
54. Hamilton-Dutoit SJ, Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am J Pathol 1992;140:1315-25.
55. Kieff E, Leibowitz D. Oncogenesis by herpesvirus. In: Weinberg RA, ed. Oncogenes and the molecular origin of cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989:259.
56. Neri A, Barriga F, Inghirami G. et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome - associated lymphoma. Blood 1991;77:1092-5.
57. Gaidano G, Ballerini P, Gong JZ, et al. p53 Mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 1991;88:5413-7.
58. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science 1991;253:49-53.
59. Gaidano G, Hauptschein RS, Parsa NZ, et al. Deletions involving two distinct regions of 6q in B-cell non Hodgkin lymphoma. Blood 1992;80:1781-7.
60. Chaganti RS, Jhanwar SC, Koziner B, Arlin Z, Mertelsmann R, Clarkson BD. Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome. Blood 1983;61:1265-8.
61. Groopman JE, Sullivan JL, Mulder C, et al. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood 1986;67: 612-5.
62. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988;72:667-71.
63. Ballerini P, Gaidano G, Gong JZ, et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993;81:166-76.
64. Gaidano G, Parsa NZ, Tassi V, et al. In vitro establishment of AIDS-relaled lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection. Leukemia 1993;7:1621-9.
65. Shibata D, Weiss LM, Nathwani BN, Brynes RK, Levine AM. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991;77:1527-33.
66. Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M. Human immunodeficiency virus - associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 1993;11: 1674-81.
67. Polito P, Cilia AM, Gloghini A, et al. High frequency of EBV association with non-random abnormalities of the chromosome region 1q21-25 in AIDS-related Burkitt's lymphoma - derived cell lines. Int J Cancer 1995;61:370-4.
68. Gaidano G, Lo Coco F, Ye BH, et al. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome - associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 1994;84:397-402.
69. Gaidano G, Carbone A, Pastore C, et al. Frequent mutation of the 5′ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome - related non-Hodgkin's lymphomas. Blood 1997;89:3755-62.
70. Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL-6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A 1995;92: 12520-4.
71. Levine PH, Kamaraju LS, Connelly RR, Berard CW, Dorfman RF, Magrath I, Easton JM. The American Burkitt's Lymphoma Registry: eight years' experience. Cancer 1982;49: 1016-22.
72. Robbins KT, Fuller LM, Manning MD, et al. Primary lymphoma of the mandible. Head Neck Surg 1986;8:192-9.
73. Sariban E, Donahue A, Magrath IT. Jaw involvement in American Burkitt's lymphoma. Cancer 1984;53:1777-82.
74. Kraus M, Fliss DM, Argov S, Leiberman A, Benharroch D. Burkitt's lymphoma of the tonsil. J Laryngol Otol 1990;104: 991-4.
75. Wang MB, Strasnick B, Zimmerman MC. Extranodal American Burkitt's lymphoma of the head and neck. Arch Otolaryngol Head Neck Surg 1992;118:193-9.
76. Tewfik TL, Bond M, AI-Ghamdi K, Bernard C. Burkitt's lymphoma of the tonsil in children. J Otolaryngol 1996;25:205-8.
77. Standefer JA, Mattox DE, Aufdemorte TB, Geiser CF, Gates GA. Midfacial Burkitt's lymphoma. Otolaryngol Head Neck Surg 1985;93:262-7.
78. Takahashi H, Fujita S, Okabe H, Tsuda N, Tezuka F. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity. Pathol Res Pract 1993;189:300-11.
79. Bauer GP, Volk MS, Siddiqui SY, et al. Burkitt's lymphoma of the parapharyngeal space. Arch Otolaryngol Head Neck Surg 1993;119:117-20.
80. Topping JW III, Kennedy JL, Sharon BI, Mafee MF, Tojo DP. Pathologic quiz case 1. Arch Otolaryngol Head Neck Surg 1997;123:230, 232-3.
81. Vinayak BC, Reddy KTV, Fulton J, Milford CA. Pediatric nonendemic Burkitt's lymphoma of the head and neck. Ann Otol Rhinol Laryngol 1994;103:238-40.
82. Lazar RH, Gurucharri MJ, Edwards O, Presbury G. Pathologic quiz case 2. Arch Otolaryngol Head Neck Surg 1989;115: 636-7, 639.
83. Edelstein C, Shields JA, Shields CL, et al. Non-African Burkitt lymphoma presenting with oral thrush and an orbital mass in a child. Am J Ophthalmol 1997;124:859-61.
84. Weisberger EC, Davidson DD. Unusual presentations of lymphoma of the head and neck in childhood. Laryngoscope 1990;100:337-42.
85. Welling DB, McCabe BF. American Burkitt's lymphoma of the mastoid. Laryngoscope 1987;97:1038-42.
86. Michaels L. Pathology of the larynx. Berlin, Germany: Springer-Verlag, 1984:334-5.
87. Philip T, Pikerton R, Biron P, et al. Effective multiagent chemotherapy in children with advanced B-cell lymphoma: who remains the high risk patient? Br J Haematol 1987;65:159-64.
88. Anavi Y, Kaplinsky C, Calderon S, Zaizov R. Head, neck, and maxillofacial childhood Burkitt's lymphoma: a retrospective analysis of 31 patients. J Oral Maxillofac Surg 1990;48:708-13.